Patent Rights in the COVID age. Fostering Innovation, Securing Universal Access and Limitations on Public Interest Considerations

Roberto Vargas

Roberto Vargas

Pfizer Inc. - USA
Carolina Tauk

Caroline Tauk

Federal Judge of Rio de Janeiro - Brazil
Andrés Rincón

Andrés Rincón

Cavelier Abogados - Colombia
Alexander Agudelo

Alexander Agudelo

OlarteMoure - Colombia

Patent Rights in the COVID age. Fostering Innovation, Securing Universal Access and Limitations on Public Interest Considerations

In an unprecedented effort, pharmaceutical companies and scientific research institutes are striving to develop a vaccine and secure IP protection for it.  The question of universal access arises: Will governments be able to obtain affordable vaccines when they become available? Can patent owners be forced to license the COVID-19 vaccine for the greater good? Are we using the IP system to create the right incentives?

102